216 results on '"Rutten, Frans F."'
Search Results
52. The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk
53. VALUING QALY GAINS BY APPLYING A SOCIETAL PERSPECTIVE
54. UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS
55. Incorporation of economic evidence in the Dutch guideline ‘cardiovascular risk management’
56. Health Effects in Significant Others
57. The efficiency frontier approach to economic evaluation: will it help German policy making?
58. Multidisciplinary Collaborative Care for Depressive Disorder in the Occupational Health Setting: design of a randomised controlled trial and cost-effectiveness study
59. Costs and prices of single dental fillings in Europe: a micro-costing study
60. Cost-effectiveness of neonatal surgery: first greeted with scepticism, now increasingly accepted
61. Stochastic league tables: an application to diabetes interventions in the Netherlands
62. Intrauterine Insemination or In-Vitro Fertilisation in Idiopathic Subfertility and Male Subfertility: A Randomised Trial and Cost-Effectiveness Analysis
63. VALUING QALY GAINS BY APPLYING A SOCIETAL PERSPECTIVE.
64. Factors to Consider When Designing Phase III Clinical Trials Involving Economic Evaluations
65. THE VALUATION OF INFORMAL CARE IN ECONOMIC APPRAISAL
66. Patient and Informal Caregiver Time in Cost-Effectiveness Analysis:A Response to the Recommendations of the Washington Panel
67. Lifetime costs of lung transplantation: estimation of incremental costs
68. Productivity Costs Measurement Through Quality of Life? A Response to the Recommendation of the Washington Panel
69. The Role of a Decision Rule in Symptomatic Pulmonary Embolism Patients with a Non-high Probability Ventilation-perfusion Scan
70. The cost-effectiveness of diagnostic strategies in patients with suspected pulmonary embolism
71. Labor and Health Status in Economic Evaluation of Health Care: The Health and Labor Questionnaire
72. New Options in Long-Term Care for the Elderly
73. The impact of indirect costs on outcomes of health care programs
74. Costs, effects and C/E‐ratios alongside a clinical trial
75. THE COST-EFFECTIVENESS OF PRESERVATION WITH UW AND EC SOLUTION FOR USE IN CADAVERIC KIDNEY TRANSPLANTATION IN THE CASE OF SINGLE KIDNEY DONORS
76. Health Effects in Significant Others: Separating Family and Care-Giving Effects.
77. Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach.
78. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics.
79. Stochastic league tables: an application to diabetes interventions in the Netherlands.
80. Multivariate Markov chain analysis of the probability of pregnancy in infertile couples undergoing assisted reproduction.
81. The friction cost method for measuring indirect costs of disease.
82. Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington Panel.
83. Book Review
84. Lifetime costs of lung transplantation: estimation of incremental costs
85. THE COSTEFFECTIVENESS OF PRESERVATION WITH UW AND EC SOLUTION FOR USE IN CADAVERIC KIDNEY TRANSPLANTATION IN THE CASE OF SINGLE KIDNEY DONORS
86. Reply to Johanneson's and Karlsson's comment.
87. Intrauterine Insemination or In-VitroFertilisation in Idiopathic Subfertility and Male Subfertility A Randomised Trial and Cost-Effectiveness Analysis
88. The Marketplace for Medical Technology
89. Technology Assessment in Europe: Its Present and Future Roles
90. Economic Techniques for Technology Assessment
91. A Working View of Technology Assessment: The Case of Digital Subtraction Angiography
92. The Transfer of Medical Technology in Developing Countries: The Case of Brazil
93. Public Control of the Diffusion of Health Technology
94. Diffusion of Medical Technology: A Case Study of Policy in Europe and the Netherlands
95. The Birth and Development of an Innovation: The Case of Magnetic Resonance Imaging
96. The Early Assessment of Health Care Technology: Introducing the Artificial Heart
97. Changing Environment: Decentralized Use of Medical Technology
98. Educational Aspects of the Economics of Medical Technology
99. General Conclusions
100. Economics and the Rational Use of Medical Technology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.